A Pilot Evaluation of the Pregnant Moms' Empowerment Program

Sponsor
University of Notre Dame (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05011825
Collaborator
University of Memphis (Other)
137
2
2
81.5
68.5
0.8

Study Details

Study Description

Brief Summary

This project will use a longitudinal design with assessments at baseline (T1), post-treatment (T2), 3 month post-partum (T3), 1 year postpartum (T4) and 3.5-5 years postpartum to examine whether the PMEP improves participants': a) mental health (depression, PTSD) and resilience,

  1. parenting skills, c) birth, infant, and toddler developmental outcomes, and d) lowers re-victimization rates. We hypothesize significantly improved outcomes in the intervention group compared to the control group at post-treatment and at all follow-ups. The pilot will use a quasi-randomized design, with participants assigned to alternating treatment and control blocks. Analyses will be conducted using intent to treat and per protocol methods. Following group assignment, all women will be scheduled for a baseline interview at a time convenient for the participant. Participant interviews will take approximately 1.5 hours. Mothers will be compensated with a gift card in the amount of 40 USD for each interview. In addition to the core evaluation metrics, mothers' demographic information will be obtained (age, relationship status, employment, education, number of children, income). Following the baseline interview, the PMEP will be provided to the treatment group; participants will receive 2-hours of contact time per week for 5 weeks (2-hour sessions, held once weekly). Women will receive reminder calls the day of each session to identify and resolve any barriers to attendance (e.g., transportation). Taxi fare will be supported for women who are unable to obtain transportation if the bus is not feasible. Following the completion of the PMEP groups or - for the control group - after 5-6 weeks has passed, all participants will complete a second interview. This interview will include all of the core measures of hypothesized treatment change, thereby permitting a comparison between women in the treatment and control groups over time. All women will be invited in a third time when their infant is 3 months old and again when their infant is 1 year of age to evaluate parenting and infant outcomes. Women will participate in a brief phone assessment when their children are between 3.5 and 5 years of age that includes all primary study outcomes.
Condition or Disease Intervention/Treatment Phase
  • Behavioral: Pregnant Moms' Empowerment Program
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
137 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
A Pilot Evaluation of the Pregnant Moms' Empowerment Program
Actual Study Start Date :
Mar 15, 2017
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pregnant Moms' Empowerment Program

The PMEP is a 5-session program, delivered prenatally. The first three sessions address violence and mental health and the final two sessions address labor/delivery, infant health and early parenting.

Behavioral: Pregnant Moms' Empowerment Program
The first session introduces women to the group, seeks to build an alliance and sense of group cohesion, and provides safety planning. The second session addresses intergenerational patterns of violence and how such violence contributes to psychopathology in both the prenatal and postnatal period, focusing on violence prevention. Information regarding cognitive restructuring, behavioral activation, and coping styles is provided in session three, as well as the role of healthy relationships and social supports in promoting resilience. This session begins with discussion on health in pregnancy, labor/delivery, and coordinating care across providers. This session also provides psychoeducation related to post-delivery parenting, including infant safety, care and breastfeeding. In the final session, group leaders assist mothers with identification, sensitivity, and responsiveness to infant cues.

No Intervention: Control

Control group participants received information about community resources, but did not receive any study-related intervention.

Outcome Measures

Primary Outcome Measures

  1. Center for Epidemiological Studies Depression Scale [Change from baseline assessment to post-test (5-6 weeks later)]

    Depression

  2. Center for Epidemiological Studies Depression Scale [Change from baseline assessment to 3 months postpartum]

    Depression

  3. Center for Epidemiological Studies Depression Scale [Change from baseline assessment to 12 months postpartum]

    Depression

  4. Center for Epidemiological Studies Depression Scale [Change from baseline assessment to 3.5-5 years postpartum]

    Depression

  5. PTSD Checklist - 5 [Change from baseline assessment to post-test (5-6 weeks later)]

    Posttraumatic Stress

  6. PTSD Checklist - 5 [Change from baseline assessment to 3 months postpartum]

    Posttraumatic Stress

  7. PTSD Checklist - 5 [Change from baseline assessment to 12 months postpartum]

    Posttraumatic Stress

  8. PTSD Checklist - 5 [Change from baseline assessment to 3.5-5 years postpartum]

    Posttraumatic Stress

  9. Connors Davidson Resilience Scale [Change from baseline assessment to post-test (5-6 weeks later)]

    Resilience

  10. Connors Davidson Resilience Scale [Change from baseline assessment to 3 months postpartum]

    Resilience

  11. Connors Davidson Resilience Scale [Change from baseline assessment to 12 months postpartum]

    Resilience

  12. Connors Davidson Resilience Scale [Change from baseline assessment to 3.5-5 years postpartum]

    Resilience

  13. Conflict Tactics Scales - Revised [Change from baseline assessment to post-test (5-6 weeks later)]

    Intimate Partner Violence

  14. Conflict Tactics Scales - Revised [Change from baseline assessment to 3 months postpartum]

    Intimate Partner Violence

  15. Conflict Tactics Scales - Revised [Change from baseline assessment to 12 months postpartum]

    Intimate Partner Violence

  16. Conflict Tactics Scales - Revised [Change from baseline assessment to 3.5-5 years postpartum]

    Intimate Partner Violence

  17. Adult Adolescent Parenting Inventory [Change from baseline assessment to post-test (5-6 weeks later)]

    Parenting Attitudes

  18. Adult Adolescent Parenting Inventory [Change from baseline assessment to 3 months postpartum]

    Parenting Attitudes

  19. Adult Adolescent Parenting Inventory [Change from baseline assessment to 12 months postpartum]

    Parenting Attitudes

  20. Adult Adolescent Parenting Inventory [Change from baseline assessment to 3.5-5 years postpartum]

    Parenting Attitudes

  21. Karitane Parenting Inventory [Change from baseline assessment to post-test (5-6 weeks later)]

    Parenting Confidence

  22. Karitane Parenting Inventory [Change from baseline assessment to 3 months postpartum]

    Parenting Confidence

  23. Karitane Parenting Inventory [Change from baseline assessment to 12 months postpartum]

    Parenting Confidence

  24. Pregnancy Risk and Monitoring System (PRAMS) [Differences between groups at 3 months postpartum]

    Labor, Delivery and Breastfeeding

  25. Pregnancy Risk and Monitoring System (PRAMS) [Differences between groups at 12 months postpartum]

    Labor, Delivery and Breastfeeding

  26. Infant Development [Difference between groups at 12 months post partum]

    Bayley Scales of Infant Development

  27. Infant Development [Differences between groups at 3 months postpartum]

    Bayley Scales of Infant Development

  28. Infant Behavior Questionnaire [Differences between groups at 12 months post partum]

    Infant Temperament

  29. Maternal Sensitivity and Infant Affect Regulation [Differences between groups at 3 months postpartum]

    Coded free play data

  30. Maternal Sensitivity and Infant Affect Regulation [Differences between groups at 12 months postpartum]

    Coded free play data

Secondary Outcome Measures

  1. Lubben Social Network Scale [Change from baseline to posttest (5-6 weeks later)]

    Social Support

  2. Lubben Social Network Scale [Change from baseline to 3 months postpartum]

    Social Support

  3. Lubben Social Network Scale [Change from baseline to posttest 12 months postpartum]

    Social Support

  4. Lubben Social Network Scale [Change from baseline to posttest 3.5-5 years postpartum]

    Social Support

  5. Rotter Locus of Control Scale [Change from baseline to post-test (5-6 weeks later)]

    Locus of Control

  6. Rotter Locus of Control Scale [Change from baseline to 3 months postpartum]

    Locus of Control

  7. Rotter Locus of Control Scale [Change from baseline to 12 months postpartum]

    Locus of Control

  8. Child behavior checklist [3.5-5 years postpartum]

    Child adjustment

Other Outcome Measures

  1. Breastfeeding Behavior Scale [Differences between groups at 12 months post partum]

    Breastfeeding attitudes

  2. Postpartum Depression Scale [3 months postpartum]

    Postpartum depression

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • at least 16 years of age

  • experienced IPV in the past year

  • currently pregnant (<33 weeks)

  • English speaking

Exclusion Criteria:
  • insufficient fluency in English to participate in interviews/groups

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of NotreDame Notre Dame Indiana United States 46556
2 University of Memphis Memphis Tennessee United States 38152

Sponsors and Collaborators

  • University of Notre Dame
  • University of Memphis

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Notre Dame
ClinicalTrials.gov Identifier:
NCT05011825
Other Study ID Numbers:
  • 17-08-4035
First Posted:
Aug 18, 2021
Last Update Posted:
Aug 18, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2021